Variant Perception

Figures converted from INR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Where We Disagree With the Market

The market is debating the wrong variable. Consensus treats Waaree's 25% OPM as either "structural from cell integration" (bull) or "policy artifact from ALMM/BCD" (bear), and both sides focus on the US tariff stack as the swing factor. Our evidence suggests neither framing captures the decisive shift: the ALMM cell mandate (June 2026) is about to create a domestic cell oligopoly — 27 GW of qualifying cell capacity serving 165 GW of module demand — and Waaree owns 20% of the bottleneck. The market prices this as "generally positive for Indian solar." It is specifically transformative for the three to four companies with qualifying cell lines, and it means that domestic margin power may actually increase even as the US export channel degrades. The resolution comes fast: post-June 2026 DCR module pricing and Q1 FY27 OPM will tell us whether cell scarcity translates into margin expansion or gets competed away.

Variant Perception Scorecard

Variant strength is moderate-to-high at 62. The cell oligopoly thesis is material and testable, but conditional on ALMM enforcement rigor and whether the 27 GW cell figure holds (new entrants could qualify). Consensus clarity is 70 — the bull/bear split is observable in the Kotak SELL ($27) versus Emkay BUY ($45) spread, but neither side has explicitly modeled the cell bottleneck as the primary margin driver. Evidence strength is 65 — ICRA, Wood Mackenzie, and Motilal Oswal all flag overcapacity at the module level, but the cell constraint is quantifiable only from ALMM-II registration data. Resolution is 2-3 months: June 2026 ALMM cell mandate enforcement and July 2026 US AD final determination together collapse the uncertainty window.

Consensus Map

The Disagreement Ledger

Disagreement 1 — Cell oligopoly mispricing. Consensus would say the ALMM cell mandate is a general tailwind for Indian solar manufacturing, benefiting all domestic players with cell capacity. Our evidence disagrees: India will have 165 GW of module capacity by March 2027 (per ICRA) but only 27 GW of ALMM-qualifying cell capacity (per Motilal Oswal). That is a 6:1 module-to-cell ratio. Module-only manufacturers face a structurally oversupplied market (60-65 GW annual output vs 45-50 GW annual demand per ICRA). But cell-integrated players control the bottleneck — every solar project commissioned after June 1, 2026 must use domestic-cell modules. Waaree owns 5.4 GW of this 27 GW bottleneck — roughly 20%. If the market concedes this is a margin concentrator and not just a policy tailwind, the DCR premium should widen materially beyond the current 300-350 bps. The cleanest disconfirming signal would be 10 or more manufacturers qualifying on ALMM List-II with combined capacity exceeding 50 GW, diluting the bottleneck.

Disagreement 2 — US tariff and domestic cell mandate as partial offsets. A consensus bear would say: US tariffs destroy 35% of revenue (direct exports) while domestic overcapacity (165 GW vs 45-50 GW demand) compresses margins on the remainder. Our evidence complicates this: the US tariff wall forces Indian manufacturers to redirect capacity toward the domestic market, which increases module-level competition. But the ALMM cell mandate simultaneously creates a domestic cell bottleneck that benefits the exact same cell-integrated players being hurt by US tariffs. Waaree's cell assets become more valuable domestically precisely when the US channel closes. If we are right, the bear-case $26 floor (based on 15% OPM on compressed revenue) is too pessimistic — the domestic cell premium should support 18-20% OPM even in a US-impaired scenario. The disconfirming signal: if cell capacity additions accelerate so fast that the bottleneck evaporates by FY28, the offset disappears.

Disagreement 3 — Order book renegotiation timing. Consensus reacted to the CVD and AD announcements as immediate impairment events — the stock dropped 10.4% and 5% on respective trading days. But order book renegotiation in the solar industry is not instantaneous: contracts carry advance payments (5-15%), bilateral terms require mutual agreement, and the 2.6 GW US factory (expanding with Meyer Burger's 1 GW) can absorb a portion of US-bound orders at IRA-credit-enhanced margins. The market may be front-loading 12-18 months of gradual drag into single-day price drops. If correct, the tactical implication is that tariff headline sell-offs create entry points. What would make us wrong: if major customers invoke force majeure or walk away from advances, converting a drag into a cliff.

Evidence That Changes the Odds

How This Gets Resolved

What Would Make Us Wrong

The cell oligopoly thesis rests on two pillars: that ALMM-II enforcement is strict and that qualifying cell capacity remains scarce. If the government publishes an ALMM List-II with 10 or more manufacturers and total qualifying cell capacity exceeding 50 GW, the bottleneck dissolves and there is no pricing power to concentrate. This is plausible: India's cell capacity has been expanding rapidly (projected 70 GW by March 2027 per ICRA), and the distinction between "installed capacity" and "ALMM-qualifying capacity" may narrow as manufacturers upgrade and certify. The 27 GW figure from Motilal Oswal may already be stale by June 2026.

The US tariff offset thesis assumes that domestic cell pricing power compensates for lost US export margin. But the domestic solar market is not a static pool — 45-50 GW of annual installations is growing, but so is the installed base of module capacity (165 GW). If installations disappoint (policy delays, land acquisition bottlenecks, transmission constraints), even cell-integrated players face volume pressure. The 60-65 GW annual module output against 45-50 GW demand means even cell-scarce manufacturers will compete aggressively on non-DCR modules, depressing blended realisations. If Waaree's domestic volume cannot replace US volume, the net effect is still margin compression — just less severe than the bear case implies.

The timing thesis (gradual drag, not cliff) could also be wrong. Indian solar export contracts may not be as sticky as we assume. If US customers have tariff-adjustment clauses or if financing conditions force renegotiation, the order book could reprice faster than 12-18 months. The CBP EAPA investigation adds a parallel risk: an adverse finding could trigger retroactive duty assessments on historical imports, converting a forward-looking drag into a backward-looking liability.

Finally, the entire variant rests on policy continuity. The ALMM cell mandate, BCD, and DCR are government-granted protections that have been suspended before (2023 ALMM suspension cratered OPM to 4%). A political shift, a bilateral trade deal with the US, or a government decision to prioritise installation speed over domestic manufacturing could undermine the cell oligopoly before it fully materialises.

The first thing to watch is the ALMM List-II publication — the number of qualifying manufacturers and their total cell capacity will determine within days whether the 6:1 bottleneck is real or already eroding.